Supremex (SXP) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Q1 2026 revenue rose 6.6% year-over-year to CAD 74.8 million, driven by growth in both Envelope and Packaging & Specialty Products segments.
Adjusted EBITDA increased to CAD 9.9 million (13.2% margin), up from CAD 8.8 million (12.6%) last year.
Net earnings declined to CAD 0.8 million (CAD 0.03/share) from CAD 1.9 million (CAD 0.08/share) year-over-year, mainly due to restructuring and tax items.
Strategic acquisitions and operational optimizations, including iFlex Labels and Fantasia Printing Ltd., are expected to yield significant cost savings and expand label capabilities.
Financial highlights
Envelope revenue grew 5.0% to CAD 50.9 million; Packaging & Specialty Products revenue up 10.0% to CAD 24.0 million.
Adjusted net earnings were CAD 1.9 million (CAD 0.08/share), down from CAD 2.2 million (CAD 0.09/share) last year.
Net cash flow from operations was CAD -0.8 million, compared to CAD +7.0 million last year, mainly due to working capital requirements and tax settlements.
Free cash flow was CAD -1.8 million, down from CAD +6.8 million a year ago.
Net debt stood at CAD 4.1 million, with a net debt to Adjusted EBITDA ratio of 0.13x.
Outlook and guidance
Management remains cautiously optimistic, expecting gradual improvement in operating conditions through 2026, with a focus on productivity, footprint optimization, and leveraging sales capabilities.
Expansion in the U.S. envelope market and cost control are expected to drive future growth.
Ongoing appetite for tuck-in and larger acquisitions, especially in Packaging & Specialty Products, to support long-term growth.
Short-term concerns include economic volatility, trade uncertainty, and postal service challenges.
Latest events from Supremex
- Q4 2025 revenue grew 5.6%, margins fell, and net debt dropped sharply after key acquisitions.SXP
Q4 202519 Feb 2026 - Revenue down 3.3%, but cost savings and cash flow drive debt reduction and share buybacks.SXP
Q2 20242 Feb 2026 - Net loss from asset impairment, but dividend raised and sale-leaseback planned.SXP
Q3 202415 Jan 2026 - Q4 2024 saw margin gains and debt reduction, with cost savings to drive future improvement.SXP
Q4 202416 Dec 2025 - Revenue fell 4.8–4.9% year-over-year as envelope sales declined, but packaging grew 11.6%.SXP
Q2 202524 Nov 2025 - Packaging growth and improved cash flow offset envelope decline and support strategic priorities.SXP
Q1 202521 Nov 2025 - Q3 2025 saw lower revenue but improved earnings, debt reduction, and shareholder returns.SXP
Q3 202514 Nov 2025